Shingo Dan
Impact in
- Horticulture top 2%
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 15
- Ubiquitin and proteasome pathways 7
- Phytochemical compounds biological activities 7
- Cancer therapeutics and mechanisms 6
- Protein Kinase Regulation and GTPase Signaling 5
- Oncology 20
- Co-authors
- Takao Yamori (45 shared papers)Kanami Yamazaki (17 shared papers)Takashi Tsuruo (5 shared papers)Mikihiko Naito (6 shared papers)Tetsuo Mashima (12 shared papers)Mutsumi Okamura (20 shared papers)Dexin Kong (7 shared papers)Hiroyuki Seimiya (10 shared papers)
- Journals
- Cancer Science (12 papers)Biochemical and Biophysical Research Communications (5 papers)Cancer Research (4 papers)Biological and Pharmaceutical Bulletin (4 papers)European Journal of Medicinal Chemistry (3 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Shingo Dan
89 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 114
- Horticulture 80
- Molecular Biology 1.3k
- Cancer Research 263
- Oncology 447
- Hematology 181
Countries citing papers authored by Shingo Dan
This map shows the geographic impact of Shingo Dan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Dan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Dan more than expected).
Fields of papers citing papers by Shingo Dan
This network shows the impact of papers produced by Shingo Dan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Dan. The network helps show where Shingo Dan may publish in the future.
Co-authors
The 25 scholars most cited alongside Shingo Dan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. | 2002 | 208 |
| 2 | 1999 | 159 | |
| 3 | 2000 | 137 | |
| 4 | 1998 | 119 | |
| 5 | 2018 | 104 | |
| 6 | 2010 | 95 | |
| 7 | 2020 | 83 | |
| 8 | 2005 | 66 | |
| 9 | 2011 | 65 | |
| 10 | 2010 | 65 | |
| 11 | 2016 | 53 | |
| 12 | 2014 | 50 | |
| 13 | 2018 | 46 | |
| 14 | 1998 | 42 | |
| 15 | 2008 | 42 | |
| 16 | 2019 | 41 | |
| 17 | 2015 | 40 | |
| 18 | 2001 | 38 | |
| 19 | 2021 | 37 | |
| 20 | 2016 | 37 |
About Shingo Dan
Shingo Dan is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cell Biology and Biochemistry, having authored 94 papers that have together received 2.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (15 papers), Traditional and Medicinal Uses of Annonaceae (9 papers), Cocoa and Sweet Potato Agronomy (9 papers), Ubiquitin and proteasome pathways (7 papers), Phytochemical compounds biological activities (7 papers), Microbial Natural Products and Biosynthesis (6 papers), Cancer therapeutics and mechanisms (6 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). The work is most often cited by research in Horticulture (80 citations), Molecular Biology (1.3k citations), Cancer Research (263 citations), Oncology (447 citations) and Hematology (181 citations). Shingo Dan has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Takao Yamori, Kanami Yamazaki, Takashi Tsuruo, Mikihiko Naito, Tetsuo Mashima, Mutsumi Okamura, Dexin Kong, Hiroyuki Seimiya, Tatsuhiko Tsunoda and Rempei Yanagawa. Their work appears in journals such as Cancer Science, Biochemical and Biophysical Research Communications, Cancer Research, Biological and Pharmaceutical Bulletin and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.